Product image of Glimepirida Aurovitas (Glimepiride) supplied by GNH India

Glimepirida Aurovitas

Active Ingredient:
Glimepiride
Origin:
EU

Glimepirida Aurovitas (Glimepiride)

Glimepirida Aurovitas is a prescription oral medication that contains the active ingredient glimepiride, a sulfonylurea used to manage blood glucose levels in adults with type 2 diabetes mellitus. It is marketed in the European Union and is available only with a doctor's prescription. The product works by stimulating insulin release from pancreatic beta cells.

Manufacturer / TM Owner

Aurovitas Spain,s.A.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glimepirida Aurovitas is indicated for the treatment of type 2 diabetes mellitus as part of a comprehensive diabetes management plan. It may be used when diet, exercise, and other oral agents are insufficient to achieve glycemic control.

  • Improves fasting and post‑prandial blood glucose levels.
  • Can be combined with metformin or other antidiabetic agents.
  • May be prescribed when lifestyle modifications alone are inadequate.
  • Used in adults with established type 2 diabetes.
  • Helps reduce HbA1c when taken as directed.

Side Effects

Glimepirida Aurovitas may cause a range of side effects, most of which are mild and transient. Serious adverse events are less common but require prompt medical attention.

Common

  • Hypoglycemia (low blood sugar)
  • Weight gain
  • Nausea or abdominal discomfort
  • Headache
  • Dizziness
  • Skin rash or itching

Serious

  • Severe hypoglycemia with loss of consciousness
  • Allergic reactions such as swelling of the face or throat
  • Hepatotoxicity (liver injury)
  • Hematologic abnormalities (e.g., leukopenia)

Precautions & Warnings

Before starting Glimepirida Aurovitas, certain precautions should be considered to ensure safe use. Patients should discuss their medical history and current conditions with a healthcare professional.

  • Assess renal and hepatic function prior to initiation.
  • Use caution in elderly patients who may be more prone to hypoglycemia.
  • Avoid use in patients with known sulfonylurea hypersensitivity.
  • Monitor blood glucose regularly to adjust dose as needed.
  • Inform the prescriber of any pregnancy or breastfeeding plans.
  • Review concomitant medications that may affect glucose levels.

Avoid Interactions

Glimepirida Aurovitas can interact with several drug classes, influencing its efficacy or increasing the risk of adverse effects. Understanding these interactions helps optimize therapy.

Avoid

  • Other sulfonylureas or insulin secretagogues (risk of severe hypoglycemia).
  • Strong CYP2C9 inhibitors such as fluconazole or amiodarone (may increase glimepiride levels).
  • High‑dose aspirin or NSAIDs that can affect renal function.

Use with caution

  • Beta‑blockers (may mask hypoglycemia symptoms).
  • Thiazide diuretics (can raise blood glucose).
  • ACE inhibitors or ARBs (monitor renal function and potassium).
  • Alcohol (enhances hypoglycemic effect).

Frequently Asked Questions

The active ingredient in Glimepirida Aurovitas is glimepiride, a sulfonylurea class oral antidiabetic medication.

Glimepiride stimulates insulin release from pancreatic beta cells by binding to the sulfonylurea receptor (SUR1) on ATP‑sensitive potassium channels, leading to cell depolarization and increased insulin secretion.

Glimepirida Aurovitas is marketed in the European Union and is not specifically listed as an FDA‑approved product in the United States.

Yes, glimepiride is often combined with metformin to improve glycemic control, but the combination should be prescribed and monitored by a healthcare professional.

Common side effects include hypoglycemia, weight gain, nausea, headache, dizziness, and mild skin rash.

Medical attention is needed for severe hypoglycemia, signs of an allergic reaction (such as swelling or difficulty breathing), or symptoms of liver injury like jaundice.

Patients should maintain a consistent carbohydrate intake and avoid excessive alcohol, which can increase the risk of hypoglycemia.

Blood glucose should be monitored regularly as advised by the prescribing clinician, often before meals and at bedtime, especially when therapy is initiated or dose changes.

The safety of glimepiride during pregnancy has not been established; pregnant women should discuss alternative treatments with their healthcare provider.

If a dose is missed, the patient should take it as soon as remembered unless it is near the time of the next scheduled dose. They should not double the dose.

Yes, OTC drugs such as certain NSAIDs, aspirin, and some antihistamines can influence blood sugar control or renal function and should be discussed with a pharmacist or physician.

Periodic monitoring of fasting blood glucose, HbA1c, liver function tests, and renal function is recommended to assess efficacy and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glimepiride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT